Asia-Pacific Cancer Tubulin Inhibitors Market Analysis 2012-2017 and Forecast 2018-2023

April 2018 | 104 pages | ID: A290CB218B1EN
99Strategy

Abstracts

SNAPSHOT

The Asia-Pacific Cancer Tubulin Inhibitors market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Cancer Tubulin Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Docetaxel
• Trastuzumab Emtansine
• Abraxane
• Brentuximab Vedotin
• Cabazitaxel

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Abraxis Biosciences
• Agensys
• Amgen
• Celgene
• Eagle Pharmaceuticals
• Endocyte
• Genentech
• Immunogen
• Modra Pharmaceuticals
• Pierre Fabre
• Roche
• Sanofi-Aventis
• Seattle Genetics
• Tocris Bioscience

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Non Small Cell Lung Cancer
• Prostate Cancer
• Breast Cancer
• Colorectal Cancer
• Ovarian Cancer

Region Coverage (Regional Production, Demand & Forecast by Regions etc.):

• China
• Japan & Korea
• India
• Southeast Asia
• Oceania

Contents

1 INDUSTRY OVERVIEW

1.1 Cancer Tubulin Inhibitors Industry
  1.1.1 Overview
  1.1.2 Development of Cancer Tubulin Inhibitors
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 Abraxis Biosciences (Company Profile, Products & Services, Sales Data etc.)
2.2 Agensys (Company Profile, Products & Services, Sales Data etc.)
2.3 Amgen (Company Profile, Products & Services, Sales Data etc.)
2.4 Celgene (Company Profile, Products & Services, Sales Data etc.)
2.5 Eagle Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.6 Endocyte (Company Profile, Products & Services, Sales Data etc.)
2.7 Genentech (Company Profile, Products & Services, Sales Data etc.)
2.8 Immunogen (Company Profile, Products & Services, Sales Data etc.)
2.9 Modra Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.10 Pierre Fabre (Company Profile, Products & Services, Sales Data etc.)
2.11 Roche (Company Profile, Products & Services, Sales Data etc.)
2.12 Sanofi-Aventis (Company Profile, Products & Services, Sales Data etc.)
2.13 Seattle Genetics (Company Profile, Products & Services, Sales Data etc.)
2.14 Tocris Bioscience (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 CANCER TUBULIN INHIBITORS MARKET BY TYPE

4.1 By Type
  4.1.1 Docetaxel
  4.1.2 Trastuzumab Emtansine
  4.1.3 Abraxane
  4.1.4 Brentuximab Vedotin
  4.1.5 Cabazitaxel
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Non Small Cell Lung Cancer
  5.1.2 Demand in Prostate Cancer
  5.1.3 Demand in Breast Cancer
  5.1.4 Demand in Colorectal Cancer
  5.1.5 Demand in Ovarian Cancer
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Segment of Cancer Tubulin Inhibitors
Table Asia-Pacific Cancer Tubulin Inhibitors Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Cancer Tubulin Inhibitors
Table Asia-Pacific Cancer Tubulin Inhibitors Market 2012-2023, by Application, in USD Million
Table Abraxis Biosciences Overview List
Table Cancer Tubulin Inhibitors Business Operation of Abraxis Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Agensys Overview List
Table Cancer Tubulin Inhibitors Business Operation of Agensys (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Cancer Tubulin Inhibitors Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Overview List
Table Cancer Tubulin Inhibitors Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eagle Pharmaceuticals Overview List
Table Cancer Tubulin Inhibitors Business Operation of Eagle Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endocyte Overview List
Table Cancer Tubulin Inhibitors Business Operation of Endocyte (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genentech Overview List
Table Cancer Tubulin Inhibitors Business Operation of Genentech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Immunogen Overview List
Table Cancer Tubulin Inhibitors Business Operation of Immunogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Modra Pharmaceuticals Overview List
Table Cancer Tubulin Inhibitors Business Operation of Modra Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pierre Fabre Overview List
Table Cancer Tubulin Inhibitors Business Operation of Pierre Fabre (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Cancer Tubulin Inhibitors Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi-Aventis Overview List
Table Cancer Tubulin Inhibitors Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Seattle Genetics Overview List
Table Cancer Tubulin Inhibitors Business Operation of Seattle Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tocris Bioscience Overview List
Table Cancer Tubulin Inhibitors Business Operation of Tocris Bioscience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Cancer Tubulin Inhibitors Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Cancer Tubulin Inhibitors Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Cancer Tubulin Inhibitors Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Cancer Tubulin Inhibitors Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Docetaxel
Table Major Company List of Trastuzumab Emtansine
Table Major Company List of Abraxane
Table Major Company List of Brentuximab Vedotin
Table Major Company List of Cabazitaxel
Table Asia-Pacific Cancer Tubulin Inhibitors Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Cancer Tubulin Inhibitors Market 2012-2017, by Type, in Volume
Table Asia-Pacific Cancer Tubulin Inhibitors Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Cancer Tubulin Inhibitors Market Forecast 2018-2023, by Type, in Volume
Table Cancer Tubulin Inhibitors Demand in Non Small Cell Lung Cancer, 2012-2017, in USD Million
Table Cancer Tubulin Inhibitors Demand in Non Small Cell Lung Cancer, 2012-2017, in Volume
Table Major Consumers in Non Small Cell Lung Cancer
Table Cancer Tubulin Inhibitors Demand in Prostate Cancer, 2012-2017, in USD Million
Table Cancer Tubulin Inhibitors Demand in Prostate Cancer, 2012-2017, in Volume
Table Major Consumers in Prostate Cancer
Table Cancer Tubulin Inhibitors Demand in Breast Cancer, 2012-2017, in USD Million
Table Cancer Tubulin Inhibitors Demand in Breast Cancer, 2012-2017, in Volume
Table Major Consumers in Breast Cancer
Table Cancer Tubulin Inhibitors Demand in Colorectal Cancer, 2012-2017, in USD Million
Table Cancer Tubulin Inhibitors Demand in Colorectal Cancer, 2012-2017, in Volume
Table Major Consumers in Colorectal Cancer
Table Cancer Tubulin Inhibitors Demand in Ovarian Cancer, 2012-2017, in USD Million
Table Cancer Tubulin Inhibitors Demand in Ovarian Cancer, 2012-2017, in Volume
Table Major Consumers in Ovarian Cancer
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Cancer Tubulin Inhibitors Demand Forecast 2018-2023, by Application, in USD Million
Table Cancer Tubulin Inhibitors Demand Forecast 2018-2023, by Application, in Volume
Table Cancer Tubulin Inhibitors Production 2012-2017, by Region, in USD Million
Table Cancer Tubulin Inhibitors Production 2012-2017, by Region, in Volume
Table Asia-Pacific Cancer Tubulin Inhibitors Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Cancer Tubulin Inhibitors Market Size 2012-2017, by Region, in Volume
Table China Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in USD Million
Table China Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in Volume
Table China Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in USD Million
Table China Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in Volume
Table Japan Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in USD Million
Table Japan Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in Volume
Table Japan Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in USD Million
Table Japan Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in Volume
Table India Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in USD Million
Table India Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in Volume
Table India Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in USD Million
Table India Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in Volume
Table India Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in USD Million
Table India Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in Volume
Table Oceania Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in USD Million
Table Oceania Cancer Tubulin Inhibitors Market Size 2012-2017, by Country, in Volume
Table Oceania Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in USD Million
Table Oceania Cancer Tubulin Inhibitors Market Size 2012-2017, by Type, in Volume
Table Oceania Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in USD Million
Table Oceania Cancer Tubulin Inhibitors Market Size 2012-2017, by Application, in Volume
Table Cancer Tubulin Inhibitors Market Forecast 2018-2023, by Region, in USD Million
Table Cancer Tubulin Inhibitors Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Cancer Tubulin Inhibitors

List Of Figures

LIST OF FIGURES

Figure Cancer Tubulin Inhibitors Industry Chain Structure
Figure Asia-Pacific Cancer Tubulin Inhibitors Market Size and Growth Rate 2012-2023
Figure China Cancer Tubulin Inhibitors Market, by Company, in 2018
Figure Japan & Korea Cancer Tubulin Inhibitors Market, by Company, in 2018
Figure India Cancer Tubulin Inhibitors Market, by Company, in 2018
Figure Southeast Asia Cancer Tubulin Inhibitors Market, by Company, in 2018
Figure Oceania Cancer Tubulin Inhibitors Market, by Company, in 2018
Figure Asia-Pacific Cancer Tubulin Inhibitors Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Cancer Tubulin Inhibitors Market Growth 2012-2017, by Type, in Volume
Figure China Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure China Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in Volume
Figure India Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure India Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Oceania Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure Oceania Cancer Tubulin Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview